Our Adaptive Study Design Helps You Institute In-Study Changes

In an era when the timelines involved in trials grow along with the costs to get drugs to market, sponsors are searching for ways to make go/no-go decisions earlier and make costly trials more flexible. They want to be able to change study specifications as information is gathered and while they have the study personnel and the subjects already lined up. In an effort to improve efficiency in drug development and better handle difficult, costly approval processes, some organizations are increasingly turning toward adaptive design in clinical trials, Bayesian statistical modeling and related approaches.

Adaptive study design has become increasingly adept at modifying aspects of trials while retaining integrity and validity. Though they’re far from a perfected or fix-all solution, adaptive trials offer an intriguing approach to making research more affordable and speeding drugs to the people that need them.

Ask Us How We Conduct Adaptive Clinical Trials

Datatrial has studied adaptive study design processes and can offer ways to use these techniques where appropriate in your trials. By rolling out site-based changes, we can help you to maximize your research dollars.

To find out more about how Datatrial applies adaptive design in clinical trials, be sure to contact us today. You can also download a white paper that details our approach to adaptive study design.